ADMA Biologics, Inc. ADMA

$12.73 -3.63% at last close

Recent SEC Filings

FormDescriptionFiledDocument
4 FORM 4 2026-11-05 View →
10-Q 10-Q 2026-11-04 View →
8-K 8-K 2026-11-04 View →
10-Q 10-Q 2026-08-05 View →
8-K 8-K 2026-08-05 View →
4 FORM 4 2026-07-28 View →
4 FORM 4 2026-07-17 View →
8-K 8-K 2026-06-02 View →
4 FORM 4 2026-05-28 View →
4 FORM 4 2026-05-14 View →
4 FORM 4 2026-05-12 View →
10-Q 10-Q 2026-05-06 View →
8-K 8-K 2026-05-06 View →
8-K 8-K 2026-05-04 View →
DEF 14A DEF 14A 2026-04-15 View →
4 FORM 4 2026-04-03 View →
8-K 8-K 2026-03-27 View →
4 FORM 4 2026-03-17 View →
4 FROM 4 2026-03-17 View →
4 FORM 4 2026-03-10 View →
4 FORM 4 2026-03-10 View →
4 FORM 4 2026-03-09 View →
4 FORM 4 2026-03-02 View →
8-K 8-K 2026-03-02 View →
10-K 10-K 2026-02-25 View →
8-K 8-K 2026-02-25 View →
4 FORM 4 2026-02-23 View →
4 FORM 4 2026-02-23 View →
4 FORM 4 2026-02-23 View →
4 FORM 4 2026-02-17 View →
4 FORM 4 2026-02-11 View →
4 FORM 4 2026-02-11 View →
4 FORM 4 2026-02-11 View →
4 FORM 4 2026-02-11 View →
4 FORM 4 2026-02-11 View →
4 FORM 4 2026-02-11 View →
4 FORM 4 2026-02-11 View →
4 FORM 4 2026-02-11 View →
8-K 8-K 2026-01-12 View →
4 FORM 4 2025-12-16 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$12.73
Market Cap
$2.93 billion
52-Week Range
$7.21 – $20.46
Average Volume
3.74 million shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.